Cara Therapeutics | CARA - Ebit





Ebit Veränderung Datum
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cassava Sciences USD -11.17M 2.38M 2026-03
Chugai Pharma JPY 158.77B 10.24B 2026-03
Cipla INR 6.14B 3.63B 2026-03
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 116M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
J&J USD 6.62B 1.51B 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
RedHill Biopharma USD 2.69M 47.97M 2023-06
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Vanda Pharmaceuticals USD -10.28M 721K 2024-12